O-GlcNAc modification and the tauopathies: Insights from chemical biology

Current Alzheimer Research

Volumn 6, Issue 5, 2009, Pages 451-454

  Yuzwa, Scott A ^a   Vocadlo, David J ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Glucosaminidase; Glycoside hydrolase; O GlcNAc; Phosphorylation; Tau

Indexed keywords

1,2 DIDEOXY 2' PROPYL ALPHA DEXTRO GLUCOPYRANOSO [2,1 D] DELTA2' THIAZOLINE; GLYCOSIDASE; GLYCOSIDASE INHIBITOR; N ACETYLGLUCOSAMINE; O (2 ACETAMIDO 2 DEOXY DEXTRO GLUCOPYRANOSYLIDENE)AMINO N PHENYLCARBAMATE; OKADAIC ACID; TAU PROTEIN; THIAMET G; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CONFERENCE PAPER; DRUG MECHANISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; STOICHIOMETRY; TAUOPATHY;

ACETYLGLUCOSAMINE; ANIMALS; BRAIN; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; TAU PROTEINS; TAUOPATHIES;

EID: 70249096980     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720509789207967     Document Type: Conference Paper

References (28)

1. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 24: 1121-1159 (2001).
2. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477: 90-99 (1989). (Pubitemid 19026942)
3. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261: 6084-6089 (1986). (Pubitemid 17207447)
4. Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 83: 4044-4048 (1986).
5. Ksiezak-Reding H, Liu WK, Yen SH. Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res 597: 209-219 (1992). (Pubitemid 23003689)
6. Bretteville A, Planel E. Tau aggregates: toxic, inert, or protective species? J Alzheimers Dis 14: 431-436 (2008).
7. Arnold CS, Johnson GV, Cole RN, Dong DL, Lee M, Hart, GW. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J Biol Chem 271: 28741-28744 (1996). (Pubitemid 26382566)
8. Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA 101: 10804-10809 (2004). (Pubitemid 38955823)
9. Torres CR, Hart, GW. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 259: 3308-3317 (1984).
10. Roquemore EP, Chevrier MR, Cotter RJ, Hart GW. Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin. Biochemistry 35: 3578-3586 (1996).
11. Kreppel LK, Blomberg MA, Hart GW. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 272: 9308-9315 (1997).
12. Lubas WA, Frank DW, Krause M, Hanover JA. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem 272: 9316-9324 (1997). (Pubitemid 27154944)
13. Dong DL, Hart GW. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J Biol Chem 269: 19321-19330 (1994).
14. Gao Y, Wells L, Comer FI, Parker GJ, Hart GW. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J Biol Chem 276: 9838-9845 (2001). (Pubitemid 37391884)
15. O'Donnell N, Zachara NE, Hart GW, Marth JD. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol. 24: 1680-1690 (2004). (Pubitemid 38167089)
16. Takai A, Murata M, Torigoe K, Isobe M, Mieskes G, Yasumoto T. Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship. Biochem J 284 (Pt 2): 539-544 (1992).
17. Lefebvre T, Ferreira S, Dupont-Wallois L, Bussière T, Dupire MJ, Delacourte A, et al. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins - a role in nuclear localization. Biochim Biophys Acta 1619: 167-176 (2003). (Pubitemid 36078354)
18. Horsch M, Hoesch L, Vasella A, Rast DM. N-acetylglucosaminono-1,5-lactone oxime and the corresponding (phenylcarbamoyl) oxime. Novel and potent inhibitors of beta-N-acetylglucosaminidase. Eur J Biochem 197: 815-818 (1991).
19. Li X, Lu F, Wang JZ, Gong CX. Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurosci 23: 2078-2086 (2006).
20. Zou L, Yang S, Hu S, Chaudry IH, Marchase RB, Chatham JC. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels. Shock 27: 402-408 (2007). (Pubitemid 46594972)
21. Macauley MS, Whitworth GE, Debowski AW, Chin D, Vocadlo DJ. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem 280: 25313-25322 (2005). (Pubitemid 40962233)
22. Stubbs KA, Macauley MS, Vocadlo DJ. A selective inhibitor of human lysosomal β-hexosaminidases: Gal-PUGNAc modulates levels of the ganglioside GM2 in neuroblastoma cells. Angew Chem Int Ed 48: 1300-1303 (2009).
23. Comer FI, Vosseller K, Wells L, Accavitti, MA, Hart GW. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem 293: 169-177 (2001). (Pubitemid 32547901)
24. Yuzwa SA, Macauley MS, Davies GJ, Vocadlo DJ. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 4: 483-490 (2008).
25. Li T, Hawkes C, Qureshi HY, Kar S, Paudel, HK. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β. Biochemistry 45: 3134-3145 (2006). (Pubitemid 43376331)
26. Cho JH, Johnson GV. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules. J Neurochem 88: 349-358 (2004).
27. Wang Z, Gucek M, Hart GW. Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc Natl Acad Sci USA 105: 13793-13798 (2008).
28. Gasparini L, Terni B, Spillantini MG. Frontotemporal dementia with tau pathology. Neurodegener Dis 4: 236-253 (2007).